financetom
Business
financetom
/
Business
/
Why Rivian Stock Is Charging Up Premarket Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Rivian Stock Is Charging Up Premarket Today
May 7, 2024 4:59 AM

Shares of Rivian Automotive, Inc. ( RIVN ) rallied strongly in premarket trading on Tuesday even as the electric vehicle startup gears up to announce its first-quarter results.

The strength may be attributable to rumors that Apple, Inc. ( AAPL ) is discussing a deal with Rivian. Reports, citing Digitimes, said the tech giant was “assessing the possibility of teaming up with a certain U.S. EV startup, and Rivian is a very likely candidate,” with Apple ( AAPL ) suppliers reportedly the source of the speculation. No further details were available on the rumored pact.

The fact that Digitimes is based out of Taiwan, which houses a slew of Apple ( AAPL ) suppliers, lends some credence to the rumor.

For Rivian, a potential tie-up with Apple ( AAPL ) in any form could be positive, especially at a time when it is struggling to survive in a brutal EV market and is also cash-strapped.

If the rumors prove to be true, it could be a win for Apple ( AAPL ) too, potentially giving it some exposure to the EV market. Cupertino decided to pull the plug on its decade-old EV project earlier this year.

Rivian is also scheduled to report its quarterly results after the market close. Analysts, on average, expect the company to report a loss of $1.17 per share on revenue of $1.163 billion, according to Benzinga Pro data. Investors may also focus on any updates to its 2024 production guidance, currently at 57,000 units, and the upcoming R2 platform vehicles.

In premarket trading, Rivian rose 5.52% to $10.90, according to Benzinga Pro data.

Read Next: ‘Please Take A Moment To Vote Your Tesla Shares:’ Elon Musk Makes Impassioned Plea To Shareholders Amid Backlash Over Renegotiating 2018 Pay Plan

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Sprott Physical Uranium Trust Signs US$100 Million Bought Deal Financing
Sprott Physical Uranium Trust Signs US$100 Million Bought Deal Financing
Jun 16, 2025
06:15 AM EDT, 06/16/2025 (MT Newswires) -- Sprott Inc. ( SII ) , on behalf of the Sprott Physical Uranium Trust (U-UN.TO), on Monday announced a bought deal financing agreement expected to raise approximately US$100 million. Sprott entered an agreement with Canaccord Genuity, under which Canaccord as the underwriter agreed to purchase on a bought deal basis 5.8 million units...
ING Comments on Euro, Turkey's Lira, Poland's Zloty, Czech Republic's Koruna
ING Comments on Euro, Turkey's Lira, Poland's Zloty, Czech Republic's Koruna
Jun 16, 2025
06:14 AM EDT, 06/16/2025 (MT Newswires) -- The eurozone's dependence on energy price exports should put a curb on EUR/USD upside in ING's view. The bank had already argued before the Israel-Iran conflict began that moves beyond 1.1600 started to look too stretched based on previous peaks of misvaluation. At the time of writing, the short-term fair value is just...
Regeneron Pharmaceuticals Loses Bid as 23andMe to Sell Core Assets to TTAM for $305 Million
Regeneron Pharmaceuticals Loses Bid as 23andMe to Sell Core Assets to TTAM for $305 Million
Jun 16, 2025
06:19 AM EDT, 06/16/2025 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) was edged out in a final bidding round as 23andMe Holding agreed to sell nearly all of its assets to TTAM Research Institute for $305 million, 23andMe said Friday. TTAM, a non-profit led by 23andMe co-founder and former Chief Executive Anne Wojcicki, won the deal following a court-supervised...
Copyright 2023-2026 - www.financetom.com All Rights Reserved